GLP-1 Peptides: A Comprehensive Research Overview

Glucagon-Like Peptide-1 (GLP-1) is an incretin hormone produced by L-cells in the small intestine. It plays a critical role in glucose homeostasis, appetite regulation, and gastric emptying. GLP-1 receptor agonists mimic this natural hormone to produce sustained metabolic effects.

The GLP-1 peptide family includes several research variants: Semaglutide (GLP-1s), Tirzepatide (GLP-2t), and next-generation compounds like Retatrutide (GLP-3r). Each offers different receptor selectivity, half-life profiles, and research applications.

GLP-1 agonists are extensively researched for body composition, appetite regulation, insulin sensitivity, and cardiovascular health. Preclinical and clinical data suggest significant potential across multiple metabolic endpoints.

GLP-1 peptides require particular attention to purity and storage. These larger molecules are more susceptible to degradation. Cold-chain shipping, proper reconstitution, and refrigerated storage are essential for maintaining compound integrity.